Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
BioBehavioral Research of Austin
mi
from
Austin, TX
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
BioBehavioral Research of Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Bayou City Research, Ltd.
mi
from
Houston, TX
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Houston Clinical Trials, LLC
mi
from
Houston, TX
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Murray, UT
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Murray, UT
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Associates
mi
from
Woodstock, VT
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Associates
mi
from
Woodstock, VT
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Frontier Institute
mi
from
Spokane, WA
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Frontier Institute
mi
from
Spokane, WA
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Northbrooke Research Center
mi
from
Brown Deer, WI
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Northbrooke Research Center
mi
from
Brown Deer, WI
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Sarkis Clinical Trials - Parent
mi
from
Ocala, FL
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sarkis Clinical Trials - Parent
mi
from
Ocala, FL
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
NoesisPharma
mi
from
Phoenix, AZ
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
NoesisPharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center PRIME
mi
from
Bronx, NY
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center PRIME
mi
from
Bronx, NY
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Manhattan Behavioral Medicine, LLC
mi
from
New York, NY
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Manhattan Behavioral Medicine, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
mi
from
Richardson, TX
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
mi
from
Richardson, TX
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Virginia Health System
mi
from
Charlottesville, VA
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Eastside Therapeutic Resource
mi
from
Everett, WA
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Eastside Therapeutic Resource
mi
from
Everett, WA
Click here to add this to my saved trials
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes
Status: Enrolling
Updated:  12/31/1969
Thresholds Psychiatric Rehabilitation Centers
mi
from
Chicago, IL
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes
Status: Enrolling
Updated: 12/31/1969
Thresholds Psychiatric Rehabilitation Centers
mi
from
Chicago, IL
Click here to add this to my saved trials
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Alliance Clinical Research
mi
from
Birmingham, AL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Alliance Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Harmonex Neuroscience Research
mi
from
Dothan, AL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Harmonex Neuroscience Research
mi
from
Dothan, AL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
CITrials - Bellflower
mi
from
Bellflower, CA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
CITrials - Bellflower
mi
from
Bellflower, CA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
PCSD - Feighner Research
mi
from
San Diego, CA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
PCSD - Feighner Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Clinical Research Medical Group
mi
from
Hartford, CT
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Clinical Research Medical Group
mi
from
Hartford, CT
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Palm Springs Research, LLC
mi
from
Hialeah, FL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Palm Springs Research, LLC
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
IMIC Inc.
mi
from
Homestead, FL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
IMIC Inc.
mi
from
Homestead, FL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc
mi
from
Lauderhill, FL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc
mi
from
Lauderhill, FL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Atlantic Center for Medical Research
mi
from
Atlanta, GA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Atlantic Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Northwest Behavioral Research Center
mi
from
Marietta, GA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Northwest Behavioral Research Center
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Capstone Clinical Research
mi
from
Libertyville, IL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Capstone Clinical Research
mi
from
Libertyville, IL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Baber Research Group
mi
from
Naperville, IL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Baber Research Group
mi
from
Naperville, IL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Neuroscience Research Institute, Inc
mi
from
Oak Park, IL
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Neuroscience Research Institute, Inc
mi
from
Oak Park, IL
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Associates
mi
from
Overland Park, KA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Hugo W. Moser Research Institute at Kennedy Krieger Inc.
mi
from
Baltimore, MD
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Hugo W. Moser Research Institute at Kennedy Krieger Inc.
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmsite Research Inc.
mi
from
Baltimore, MD
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmsite Research Inc.
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Neuroscientific Insights
mi
from
Rockville, MD
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Neuroscientific Insights
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Baystate Medical Center
mi
from
Springfield, MA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
Click here to add this to my saved trials